-
Cyclo (-RGDfC) for 96-Well Integrin Assays
2026-09-15
Cyclo (-RGDfC) combines cyclic RGD recognition of integrin αvβ3 with a practical DMSO-based workflow for adhesion, migration, angiogenesis, and tumor-targeting studies. Paired with an open-platform 96-well digital light printer, it supports a differentiated path from uniform peptide dosing to spatially patterned hydrogel assays, while keeping peptide handling and plate variability under control.
-
Affordable GRO-seq for Nascent RNA in Bread Wheat
2026-09-15
The reference protocol redesigns Global Run-On sequencing (GRO-seq) for complex plant genomes by adding rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation. In bread wheat, this placement increased the reported proportion of valid sequencing data 20-fold, improving the practicality of enhancer-transcription profiling without changing the core BrUTP-based assay principle.
-
Triacetin: From Acetate Donor to Assay Insight
2026-09-14
Triacetin, or glyceryl triacetate, is more than a formulation excipient: it is an acetate-bearing perturbagen that can connect metabolic, epigenetic, and cancer assays. This evidence-led guide explains how to interpret its biology, select experimental contexts, and avoid confusing solvent effects with mechanism.
-
Cholecystokinin Octapeptide Ammonium Workflow
2026-09-14
Build more informative CCK assays by pairing CCK-8 ammonium exposure with receptor controls, secreted-factor measurements, and pathway-resolved readouts. This guide translates the atrial ANP study into practical workflows while addressing peptide handling, concentration selection, and cross-model interpretation.
-
EV-ACLY Drives TAM Differentiation in HCC
2026-09-13
The reference study identifies extracellular vesicle-delivered ATP-citrate lyase as a metabolic signal that converts monocytes into immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. By engineering CD81-decorated liposomal vesicles to deliver ACLY or its inhibitor, the authors connect palmitate-dependent protein S-palmitoylation with tumor progression and improved anti-PD-1/PD-L1 responses.
-
Stable Isotope UHPLC–MS/MS for Methylated Purines
2026-09-12
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS method for quantifying 12 purine ribonucleosides, including 10 methylated species, in cultured-cell extracts. Ammonium bicarbonate-enhanced ionization, chromatographic resolution of isomers, methanol extraction, and solid-phase cleanup together improved sensitivity and enabled measurement of low-abundance RNA-derived nucleosides.
-
Merimepodib (VX-497): Translational IMPDH Strategy
2026-09-12
Merimepodib (VX-497) offers a mechanistically coherent way to interrogate guanine nucleotide dependence across antiviral, immunology, and cell-proliferation models. This thought-leadership article connects IMPDH biology with PEDV replication, experimental validation, translational positioning, and practical assay strategy while distinguishing research opportunity from clinical evidence.
-
Acetylspiramycin Workflows for Resistance Research
2026-09-11
Acetylspiramycin (Spiramycin B) connects ribosome-focused antimicrobial testing with practical studies of resistance and host response. This guide covers solvent handling, broth microdilution design, biosynthetic context, and troubleshooting for more interpretable experiments.
-
Bestatin (Ubenimex): Applied Research Workflows
2026-09-11
Bestatin (Ubenimex) enables selective aminopeptidase inhibition across enzyme, cell-based, apoptosis, and multidrug resistance workflows. This guide translates its potency profile and formulation requirements into practical assay design, controls, and troubleshooting strategies for reproducible cancer research.
-
CHI3L1-IN-5: Astrocyte Assay Workflow
2026-09-10
CHI3L1-IN-5 (Compound Z17) supports a differentiated neuroinflammation workflow by linking CHI3L1-mediated NF-κB suppression with astrocyte Aβ uptake and lysosomal readouts. This practical guide covers assay setup, dose-response design, orthogonal validation, and troubleshooting while separating product-specific evidence from a similarly named cardiovascular research compound.
-
Wnt Agonist 1: A Translational Test of Wnt Biology
2026-09-10
Wnt agonist 1, also known as BML-284, provides a practical pharmacological input for studying β-catenin–TCF signaling, cellular differentiation, and developmental biology. This thought-leadership article connects Wnt signaling pathway activation to the Wnt/NR2F2/GPX4 axis reported in lung cancer brain metastasis while outlining controls that can make translational experiments more rigorous.
-
Baicalin: Workflow for Adult Visual Plasticity
2026-09-09
Baicalin provides a practical pharmacological probe for testing whether adult visual-cortex inhibition can be reduced to restore ocular dominance plasticity. This workflow connects dose-controlled formulation, intrinsic signal optical imaging, electrophysiology, and mechanistic GABAergic assays while clearly separating vision-plasticity evidence from oncology applications.
-
Nullscript C3606: Reliable HDAC Assay Design
2026-09-09
Learn how Nullscript (SKU C3606), a histone deacetylase inhibitor, can support better-controlled viability, proliferation, cytotoxicity, and cardiac ischemia/reperfusion experiments. This scenario-based guide covers assay interpretation, stock preparation, vendor selection, and evidence limits.
-
Vernakalant for Rapid Atrial Fibrillation Conversion
2026-09-08
This phase 3 randomized trial evaluated vernakalant hydrochloride as a rapidly acting pharmacological strategy for converting atrial fibrillation to sinus rhythm. The study found substantially faster and more frequent conversion than placebo in patients with recent-onset AF, while also identifying hypotension and other clinically important adverse events that constrain interpretation and transferability.
-
GlycoRNA–RBP Surface Domains and Peptide Entry
2026-09-07
This preprint reports that cell-surface RNA-binding proteins and glycoRNAs organize into extracellular nanoclusters that support interaction with the cell-penetrating peptide TAT. Its perturbation experiments connect surface RNA to both cluster organization and peptide internalization, expanding the functional definition of the plasma membrane surface.